Latest news

ENYO Pharma selected to take part in the French Tech 120 FT120 program

ENYO Pharma has been selected to take part in the French Tech 120 #FT120 program for the second consecutive year. We will thus benefit from specific guidance and visibility. Created by the French government, this program offers support to French scaleups with the potential to become global technology leaders.

https://lafrenchtech.com/en/how-france-helps-startups/ft120/

Read more »

New publication : A new class of molecule targeting the NEET family of proteins

ENYO is proud to share international collaborative study showing the development of MITO-C (one compound of EYP002 series) a new class of molecule targeting the
NEET family of protein. This work co-led by Etienne Morel (INEM, Paris, France) and Benoît de Chassey (ENYO Pharma, Lyon France) and sponsored by ENYO Pharma nicely shows that MITO-C (one compound of EYP002 series) modulates mitochondria morphogenesis and stabilizes ER-Mitochondria contact sites. This seminal fundamental results opens potential indications that go beyond infectious diseases e.g.

Read more »

Vonafexor accepted as the generic name for EYP001 by the WHO

We are pleased to announce that the World Health Organization (WHO) has accepted the international non-proprietary name (INN, or generic name) vonafexor for our FXR agonist lead candidate previously referred to as EYP001.

Read more »

New release of neXtProt with ENYO Pharma human interactome data

ENYO Pharma and the CALIPHO group at SIB Swiss Institute of Bioinformatics are pleased to announce the neXtProt data release 2020-07-17, that integrates the human protein interactome curated by the company as “GOLD” data. This dataset includes 108,000 descriptions of protein interactions from 324 papers with the capture of the experimental method (PSI-MI). When the sequence used in the protein-protein interaction experiment is known, this information has been collected and is available in neXtProt as interaction mapping annotations.

Read more »

ENYO Pharma selected in the FrenchTech 120

ENYO Pharma is proud to be part of the FrenchTech 120 with such promising companies. It is a strong recognition from the French State.

Read more »